Please login to the form below

Not currently logged in
Email:
Password:

Merck

This page shows the latest Merck news and features for those working in and with pharma, biotech and healthcare.

Newly-listed BioNTech buys Neon to boost cell therapy assets

Newly-listed BioNTech buys Neon to boost cell therapy assets

who are not responding to treatment with checkpoint inhibitor drugs like Bristol-Myers Squibb’s Opdivo (nivolumab) and Merck &Co’s Keytruda (pembrolizumab).

Latest news

More from news
Approximately 387 fully matching, plus 1,347 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 9 fully matching, plus 128 partially matching documents found.

Latest appointments

More from appointments
Approximately 37 fully matching, plus 142 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 34 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Apex.co.uk Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading exhibition stand and event agencies, specialising in healthcare. We understand your communication goals,...

Latest intelligence

How do companies prepare for reimbursement?
Valid Insight explore how to optimise your market access strategy during new product development, how to address payer concerns and prepare for reimbursement....
EHR clinical trials
Integrating electronic health records into clinical trials
How organisations are working to realise the research potential of EHRs...
Mike Elliott Gilead
Keeping up the fight against HIV and using the lessons to tackle other threats
Danny Buckland interviews Gilead’s Mike Elliott...

Infographics